APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiovascular Interventional Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cardiovascular Interventional Devices Market Outlook and Growth Opportunities 2026

30 December 2025195 pages

Choose your research edition.

Industry ResearchCardiovascular Interventional Devices Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiovascular Interventional Devices Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Cardiovascular Interventional Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiovascular Interventional Devices Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiovascular Interventional Devices Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global top 5 players hold a market share over 70% in 2019. The key players are Boston Scientific Corporation, ABBOTT LABORATORIES, Medtronic, etc.

This report provides an overview of the global Cardiovascular Interventional Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cardiovascular Interventional Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

Read the full market overview

The report also presents Cardiovascular Interventional Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cardiovascular Interventional Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Cardiovascular Interventional Devices Segment by Company

Boston Scientific Corporation

ABBOTT LABORATORIES

Medtronic

Terumo manufacturers

NIPRO Medical Corporation

B. Braun Sharing Expertise

Cook medical

Microport

Lepumedical

Jwmedical

ASAHI INTECC

Kaneka Corporation

Sinomed

Lifetechmed

Gore

Cardiovascular Interventional Devices Segment by Type

Coronary artery stent

PTCA balloon catheter

thread

Other

Cardiovascular Interventional Devices Segment by Application

Angina pectoris

Myocardial infarction,

Other

Cardiovascular Interventional Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cardiovascular Interventional Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cardiovascular Interventional Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cardiovascular Interventional Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Cardiovascular Interventional Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Interventional Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Interventional Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Interventional Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cardiovascular Interventional Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cardiovascular Interventional Devices industry.

Chapter 3: Detailed analysis of Cardiovascular Interventional Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cardiovascular Interventional Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cardiovascular Interventional Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cardiovascular Interventional Devices Industry Trends Table 2. Cardiovascular Interventional Devices Industry Drivers Table 3. Cardiovascular Interventional Devices Industry Opportunities and Challenges Table 4. Cardiovascular Interventional Devices Industry Restraints Table 5. Global Cardiovascular Interventional Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cardiovascular Interventional Devices Revenue Share by Company (2021-2026) Table 7. Global Cardiovascular Interventional Devices Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Cardiovascular Interventional Devices Sales Volume Share by Company (2021-2026) Table 9. Global Cardiovascular Interventional Devices Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Cardiovascular Interventional Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cardiovascular Interventional Devices Key Company Manufacturing Base & Headquarters Table 12. Global Cardiovascular Interventional Devices Company, Product Type & Application Table 13. Global Cardiovascular Interventional Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cardiovascular Interventional Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Coronary artery stent Table 18. Significant Companies of PTCA balloon catheter Table 19. Significant Companies of thread Table 20. Significant Companies of Other Table 21. Global Cardiovascular Interventional Devices Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Cardiovascular Interventional Devices Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Cardiovascular Interventional Devices Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Cardiovascular Interventional Devices Sales Volume Share by Type (2021-2026) Table 25. Global Cardiovascular Interventional Devices Sales Volume Share by Type (2027-2032) Table 26. Global Cardiovascular Interventional Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cardiovascular Interventional Devices Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Cardiovascular Interventional Devices Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Cardiovascular Interventional Devices Sales Value Share by Type (2021-2026) Table 30. Global Cardiovascular Interventional Devices Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Angina pectoris Table 32. Significant Companies of Myocardial infarction, Table 33. Significant Companies of Other Table 34. Global Cardiovascular Interventional Devices Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Cardiovascular Interventional Devices Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Cardiovascular Interventional Devices Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Cardiovascular Interventional Devices Sales Volume Share by Application (2021-2026) Table 38. Global Cardiovascular Interventional Devices Sales Volume Share by Application (2027-2032) Table 39. Global Cardiovascular Interventional Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Cardiovascular Interventional Devices Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Cardiovascular Interventional Devices Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Cardiovascular Interventional Devices Sales Value Share by Application (2021-2026) Table 43. Global Cardiovascular Interventional Devices Sales Value Share by Application (2027-2032) Table 44. Global Cardiovascular Interventional Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Cardiovascular Interventional Devices Sales by Region (2021-2026) & (K Units) Table 46. Global Cardiovascular Interventional Devices Sales Market Share by Region (2021-2026) Table 47. Global Cardiovascular Interventional Devices Sales by Region (2027-2032) & (K Units) Table 48. Global Cardiovascular Interventional Devices Sales Market Share by Region (2027-2032) Table 49. Global Cardiovascular Interventional Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Cardiovascular Interventional Devices Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Cardiovascular Interventional Devices Sales Value Share by Region (2021-2026) Table 52. Global Cardiovascular Interventional Devices Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Cardiovascular Interventional Devices Sales Value Share by Region (2027-2032) Table 54. Global Cardiovascular Interventional Devices Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Cardiovascular Interventional Devices Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Cardiovascular Interventional Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Cardiovascular Interventional Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Cardiovascular Interventional Devices Sales by Country (2021-2026) & (K Units) Table 59. Global Cardiovascular Interventional Devices Sales Market Share by Country (2021-2026) Table 60. Global Cardiovascular Interventional Devices Sales by Country (2027-2032) & (K Units) Table 61. Global Cardiovascular Interventional Devices Sales Market Share by Country (2027-2032) Table 62. Global Cardiovascular Interventional Devices Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Cardiovascular Interventional Devices Sales Value Market Share by Country (2021-2026) Table 64. Global Cardiovascular Interventional Devices Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Cardiovascular Interventional Devices Sales Value Market Share by Country (2027-2032) Table 66. Boston Scientific Corporation Company Information Table 67. Boston Scientific Corporation Business Overview Table 68. Boston Scientific Corporation Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Boston Scientific Corporation Cardiovascular Interventional Devices Product Portfolio Table 70. Boston Scientific Corporation Recent Development Table 71. ABBOTT LABORATORIES Company Information Table 72. ABBOTT LABORATORIES Business Overview Table 73. ABBOTT LABORATORIES Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. ABBOTT LABORATORIES Cardiovascular Interventional Devices Product Portfolio Table 75. ABBOTT LABORATORIES Recent Development Table 76. Medtronic Company Information Table 77. Medtronic Business Overview Table 78. Medtronic Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Medtronic Cardiovascular Interventional Devices Product Portfolio Table 80. Medtronic Recent Development Table 81. Terumo manufacturers Company Information Table 82. Terumo manufacturers Business Overview Table 83. Terumo manufacturers Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Terumo manufacturers Cardiovascular Interventional Devices Product Portfolio Table 85. Terumo manufacturers Recent Development Table 86. NIPRO Medical Corporation Company Information Table 87. NIPRO Medical Corporation Business Overview Table 88. NIPRO Medical Corporation Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. NIPRO Medical Corporation Cardiovascular Interventional Devices Product Portfolio Table 90. NIPRO Medical Corporation Recent Development Table 91. B. Braun Sharing Expertise Company Information Table 92. B. Braun Sharing Expertise Business Overview Table 93. B. Braun Sharing Expertise Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. B. Braun Sharing Expertise Cardiovascular Interventional Devices Product Portfolio Table 95. B. Braun Sharing Expertise Recent Development Table 96. Cook medical Company Information Table 97. Cook medical Business Overview Table 98. Cook medical Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Cook medical Cardiovascular Interventional Devices Product Portfolio Table 100. Cook medical Recent Development Table 101. Microport Company Information Table 102. Microport Business Overview Table 103. Microport Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Microport Cardiovascular Interventional Devices Product Portfolio Table 105. Microport Recent Development Table 106. Lepumedical Company Information Table 107. Lepumedical Business Overview Table 108. Lepumedical Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Lepumedical Cardiovascular Interventional Devices Product Portfolio Table 110. Lepumedical Recent Development Table 111. Jwmedical Company Information Table 112. Jwmedical Business Overview Table 113. Jwmedical Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Jwmedical Cardiovascular Interventional Devices Product Portfolio Table 115. Jwmedical Recent Development Table 116. ASAHI INTECC Company Information Table 117. ASAHI INTECC Business Overview Table 118. ASAHI INTECC Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. ASAHI INTECC Cardiovascular Interventional Devices Product Portfolio Table 120. ASAHI INTECC Recent Development Table 121. Kaneka Corporation Company Information Table 122. Kaneka Corporation Business Overview Table 123. Kaneka Corporation Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Kaneka Corporation Cardiovascular Interventional Devices Product Portfolio Table 125. Kaneka Corporation Recent Development Table 126. Sinomed Company Information Table 127. Sinomed Business Overview Table 128. Sinomed Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Sinomed Cardiovascular Interventional Devices Product Portfolio Table 130. Sinomed Recent Development Table 131. Lifetechmed Company Information Table 132. Lifetechmed Business Overview Table 133. Lifetechmed Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Lifetechmed Cardiovascular Interventional Devices Product Portfolio Table 135. Lifetechmed Recent Development Table 136. Gore Company Information Table 137. Gore Business Overview Table 138. Gore Cardiovascular Interventional Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Gore Cardiovascular Interventional Devices Product Portfolio Table 140. Gore Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Cardiovascular Interventional Devices Distributors List Table 144. Cardiovascular Interventional Devices Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Cardiovascular Interventional Devices Product Image Figure 2. Global Cardiovascular Interventional Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cardiovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cardiovascular Interventional Devices Sales (2021-2032) & (K Units) Figure 5. Global Cardiovascular Interventional Devices Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Cardiovascular Interventional Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Coronary artery stent Image Figure 10. PTCA balloon catheter Image Figure 11. thread Image Figure 12. Other Image Figure 13. Global Cardiovascular Interventional Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Cardiovascular Interventional Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Cardiovascular Interventional Devices Sales Volume Share by Type (2021-2032) Figure 16. Global Cardiovascular Interventional Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cardiovascular Interventional Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cardiovascular Interventional Devices Sales Value Share by Type (2021-2032) Figure 19. Angina pectoris Image Figure 20. Myocardial infarction, Image Figure 21. Other Image Figure 22. Global Cardiovascular Interventional Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Cardiovascular Interventional Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Cardiovascular Interventional Devices Sales Volume Share by Application (2021-2032) Figure 25. Global Cardiovascular Interventional Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Cardiovascular Interventional Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Cardiovascular Interventional Devices Sales Value Share by Application (2021-2032) Figure 28. Global Cardiovascular Interventional Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Cardiovascular Interventional Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Cardiovascular Interventional Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Cardiovascular Interventional Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Cardiovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 33. North America Cardiovascular Interventional Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Cardiovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Cardiovascular Interventional Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Cardiovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Cardiovascular Interventional Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Cardiovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 39. South America Cardiovascular Interventional Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Cardiovascular Interventional Devices Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Cardiovascular Interventional Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Cardiovascular Interventional Devices Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Cardiovascular Interventional Devices Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Coronary artery stent
  • PTCA balloon catheter
  • thread
  • Other
Applications
  • Angina pectoris
  • Myocardial infarction,
  • Other
Companies covered
  • Boston Scientific Corporation
  • ABBOTT LABORATORIES
  • Medtronic
  • Terumo manufacturers
  • NIPRO Medical Corporation
  • B. Braun Sharing Expertise
  • Cook medical
  • Microport
  • Lepumedical
  • Jwmedical
  • ASAHI INTECC
  • Kaneka Corporation
  • Sinomed
  • Lifetechmed
  • Gore

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cardiovascular Interventional Devices Sales Value (2021-2032)
  4. 1.2.2 Global Cardiovascular Interventional Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Cardiovascular Interventional Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cardiovascular Interventional Devices Market Dynamics
  1. 2.1 Cardiovascular Interventional Devices Industry Trends
  2. 2.2 Cardiovascular Interventional Devices Industry Drivers
  3. 2.3 Cardiovascular Interventional Devices Industry Opportunities and Challenges
  4. 2.4 Cardiovascular Interventional Devices Industry Restraints
3 Cardiovascular Interventional Devices Market by Company
  1. 3.1 Global Cardiovascular Interventional Devices Company Revenue Ranking in 2025
  2. 3.2 Global Cardiovascular Interventional Devices Revenue by Company (2021-2026)
  3. 3.3 Global Cardiovascular Interventional Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Cardiovascular Interventional Devices Average Price by Company (2021-2026)
  5. 3.5 Global Cardiovascular Interventional Devices Company Ranking (2024-2026)
  6. 3.6 Global Cardiovascular Interventional Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Cardiovascular Interventional Devices Company Product Type and Application
  8. 3.8 Global Cardiovascular Interventional Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cardiovascular Interventional Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cardiovascular Interventional Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cardiovascular Interventional Devices Market by Type
  1. 4.1 Cardiovascular Interventional Devices Type Introduction
  2. 4.1.1 Coronary artery stent
  3. 4.1.2 PTCA balloon catheter
  4. 4.1.3 thread
  5. 4.1.4 Other
  6. 4.2 Global Cardiovascular Interventional Devices Sales Volume by Type
  7. 4.2.1 Global Cardiovascular Interventional Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cardiovascular Interventional Devices Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Cardiovascular Interventional Devices Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Cardiovascular Interventional Devices Sales Value by Type
  11. 4.3.1 Global Cardiovascular Interventional Devices Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cardiovascular Interventional Devices Sales Value by Type (2021-2032)
  13. 4.3.3 Global Cardiovascular Interventional Devices Sales Value Share by Type (2021-2032)
5 Cardiovascular Interventional Devices Market by Application
  1. 5.1 Cardiovascular Interventional Devices Application Introduction
  2. 5.1.1 Angina pectoris
  3. 5.1.2 Myocardial infarction,
  4. 5.1.3 Other
  5. 5.2 Global Cardiovascular Interventional Devices Sales Volume by Application
  6. 5.2.1 Global Cardiovascular Interventional Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cardiovascular Interventional Devices Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Cardiovascular Interventional Devices Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Cardiovascular Interventional Devices Sales Value by Application
  10. 5.3.1 Global Cardiovascular Interventional Devices Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cardiovascular Interventional Devices Sales Value by Application (2021-2032)
  12. 5.3.3 Global Cardiovascular Interventional Devices Sales Value Share by Application (2021-2032)
6 Cardiovascular Interventional Devices Regional Sales and Value Analysis
  1. 6.1 Global Cardiovascular Interventional Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cardiovascular Interventional Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Cardiovascular Interventional Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Cardiovascular Interventional Devices Sales by Region (2027-2032)
  5. 6.3 Global Cardiovascular Interventional Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cardiovascular Interventional Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cardiovascular Interventional Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cardiovascular Interventional Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Cardiovascular Interventional Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cardiovascular Interventional Devices Sales Value (2021-2032)
  12. 6.6.2 North America Cardiovascular Interventional Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cardiovascular Interventional Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Cardiovascular Interventional Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cardiovascular Interventional Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cardiovascular Interventional Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cardiovascular Interventional Devices Sales Value (2021-2032)
  21. 6.9.2 South America Cardiovascular Interventional Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cardiovascular Interventional Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cardiovascular Interventional Devices Sales Value Share by Country, 2025 VS 2032
7 Cardiovascular Interventional Devices Country-level Sales and Value Analysis
  1. 7.1 Global Cardiovascular Interventional Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cardiovascular Interventional Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cardiovascular Interventional Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Cardiovascular Interventional Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Cardiovascular Interventional Devices Sales by Country (2027-2032)
  6. 7.4 Global Cardiovascular Interventional Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cardiovascular Interventional Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cardiovascular Interventional Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cardiovascular Interventional Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cardiovascular Interventional Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cardiovascular Interventional Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boston Scientific Corporation
  2. 8.1.1 Boston Scientific Corporation Company Information
  3. 8.1.2 Boston Scientific Corporation Business Overview
  4. 8.1.3 Boston Scientific Corporation Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boston Scientific Corporation Cardiovascular Interventional Devices Product Portfolio
  6. 8.1.5 Boston Scientific Corporation Recent Developments
  7. 8.2 ABBOTT LABORATORIES
  8. 8.2.1 ABBOTT LABORATORIES Company Information
  9. 8.2.2 ABBOTT LABORATORIES Business Overview
  10. 8.2.3 ABBOTT LABORATORIES Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 ABBOTT LABORATORIES Cardiovascular Interventional Devices Product Portfolio
  12. 8.2.5 ABBOTT LABORATORIES Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Cardiovascular Interventional Devices Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Terumo manufacturers
  20. 8.4.1 Terumo manufacturers Company Information
  21. 8.4.2 Terumo manufacturers Business Overview
  22. 8.4.3 Terumo manufacturers Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Terumo manufacturers Cardiovascular Interventional Devices Product Portfolio
  24. 8.4.5 Terumo manufacturers Recent Developments
  25. 8.5 NIPRO Medical Corporation
  26. 8.5.1 NIPRO Medical Corporation Company Information
  27. 8.5.2 NIPRO Medical Corporation Business Overview
  28. 8.5.3 NIPRO Medical Corporation Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 NIPRO Medical Corporation Cardiovascular Interventional Devices Product Portfolio
  30. 8.5.5 NIPRO Medical Corporation Recent Developments
  31. 8.6 B. Braun Sharing Expertise
  32. 8.6.1 B. Braun Sharing Expertise Company Information
  33. 8.6.2 B. Braun Sharing Expertise Business Overview
  34. 8.6.3 B. Braun Sharing Expertise Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 B. Braun Sharing Expertise Cardiovascular Interventional Devices Product Portfolio
  36. 8.6.5 B. Braun Sharing Expertise Recent Developments
  37. 8.7 Cook medical
  38. 8.7.1 Cook medical Company Information
  39. 8.7.2 Cook medical Business Overview
  40. 8.7.3 Cook medical Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Cook medical Cardiovascular Interventional Devices Product Portfolio
  42. 8.7.5 Cook medical Recent Developments
  43. 8.8 Microport
  44. 8.8.1 Microport Company Information
  45. 8.8.2 Microport Business Overview
  46. 8.8.3 Microport Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Microport Cardiovascular Interventional Devices Product Portfolio
  48. 8.8.5 Microport Recent Developments
  49. 8.9 Lepumedical
  50. 8.9.1 Lepumedical Company Information
  51. 8.9.2 Lepumedical Business Overview
  52. 8.9.3 Lepumedical Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lepumedical Cardiovascular Interventional Devices Product Portfolio
  54. 8.9.5 Lepumedical Recent Developments
  55. 8.10 Jwmedical
  56. 8.10.1 Jwmedical Company Information
  57. 8.10.2 Jwmedical Business Overview
  58. 8.10.3 Jwmedical Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jwmedical Cardiovascular Interventional Devices Product Portfolio
  60. 8.10.5 Jwmedical Recent Developments
  61. 8.11 ASAHI INTECC
  62. 8.11.1 ASAHI INTECC Company Information
  63. 8.11.2 ASAHI INTECC Business Overview
  64. 8.11.3 ASAHI INTECC Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ASAHI INTECC Cardiovascular Interventional Devices Product Portfolio
  66. 8.11.5 ASAHI INTECC Recent Developments
  67. 8.12 Kaneka Corporation
  68. 8.12.1 Kaneka Corporation Company Information
  69. 8.12.2 Kaneka Corporation Business Overview
  70. 8.12.3 Kaneka Corporation Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Kaneka Corporation Cardiovascular Interventional Devices Product Portfolio
  72. 8.12.5 Kaneka Corporation Recent Developments
  73. 8.13 Sinomed
  74. 8.13.1 Sinomed Company Information
  75. 8.13.2 Sinomed Business Overview
  76. 8.13.3 Sinomed Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Sinomed Cardiovascular Interventional Devices Product Portfolio
  78. 8.13.5 Sinomed Recent Developments
  79. 8.14 Lifetechmed
  80. 8.14.1 Lifetechmed Company Information
  81. 8.14.2 Lifetechmed Business Overview
  82. 8.14.3 Lifetechmed Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Lifetechmed Cardiovascular Interventional Devices Product Portfolio
  84. 8.14.5 Lifetechmed Recent Developments
  85. 8.15 Gore
  86. 8.15.1 Gore Company Information
  87. 8.15.2 Gore Business Overview
  88. 8.15.3 Gore Cardiovascular Interventional Devices Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Gore Cardiovascular Interventional Devices Product Portfolio
  90. 8.15.5 Gore Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cardiovascular Interventional Devices Value Chain Analysis
  2. 9.1.1 Cardiovascular Interventional Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cardiovascular Interventional Devices Sales Mode & Process
  6. 9.2 Cardiovascular Interventional Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cardiovascular Interventional Devices Distributors
  9. 9.2.3 Cardiovascular Interventional Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst